Showing papers by "Donald A. Mahler published in 1997"

TL;DR: Inhaled salmeterol reduced dyspnea, increased airflow, and reduced hyperinflation over 4 h in patients with symptomatic COPD.

TL;DR: The authors anticipate a growing interest in measurement of clinical outcomes for patients with advanced lung diseases in the foreseeable future and expect that current instruments may be modified and that new tools will be developed in an attempt to improve the ability to measure dyspnea and HRQOL.